hg_184470.1

Basic information about the TSS

---

TSS ID: hg_184470.1 Species: human Chr: chr20		Start: 37179109 End: 37179138 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000373622.9 AK096243 Distance: 23 GeneID: 6185 HGNC/MGI_ID: HGNC:10382 UniProt_ID: P04844

Gene_name: ribophorin II Gene_symbol: RPN2 Gene_synonyms: RIBIIR RPN-II RPNII SWP1 Gene_source: HGNC:10382

TATA-Box annotation

---

Distance to TSS:	78
Nearest PromoterID:	NM_001324305
Entrez ID:	6185
Nearest Unigene:	Hs.370895
Nearest Refseq:	NM_002951
Nearest Ensembl:	ENSG00000118705
Gene Name:	ribophorin II
Gene Alias:	RIBIIR|RPN-II|RPNII|SWP1
Gene Description:	ribophorin II
Gene Type:	protein-coding
CpG%:	0.11
GC%:	0.711443
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPN2 p2@RPN2 p3@RPN2
Sample		p1@RPN2	p2@RPN2	p3@RPN2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	72.86	10.71	12.66
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	66.36	15.98	10.52
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	65.97	11.38	9.26
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	57.80	11.44	12.06
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	58.49	13.50	9.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	59.11	12.02	9.50
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	76.04	13.07	8.93
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	56.44	10.66	9.93
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	74.80	14.11	12.18
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	42.31	8.69	8.11
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	30.32	6.87	7.28
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.50	5.69	5.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	64.80	22.57	5.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	61.19	16.24	5.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	72.01	20.42	8.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	63.12	16.85	4.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	68.80	19.66	4.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	59.05	20.25	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	48.52	13.33	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	66.19	21.36	5.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	69.90	20.45	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	64.56	14.67	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	68.89	16.29	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	63.82	21.60	5.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	52.89	20.64	3.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	57.92	20.89	5.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	48.35	20.88	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	70.73	21.93	9.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	62.67	16.96	5.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	68.22	18.28	5.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	61.34	18.63	5.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	58.03	22.27	6.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	64.36	15.62	5.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	66.97	17.98	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	65.07	17.39	4.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	67.07	20.89	6.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	65.40	15.33	6.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	59.04	15.51	6.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	62.12	15.94	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	59.54	19.20	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	66.81	21.41	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	63.39	15.08	2.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	61.37	18.14	5.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	61.36	19.41	6.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	64.85	17.27	5.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	59.79	16.29	6.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	62.62	23.27	8.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	61.10	18.18	7.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	65.83	20.11	7.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	60.46	18.00	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	69.27	18.24	5.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	71.16	26.24	4.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	93.33	20.94	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	76.55	20.88	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	95.64	0.84	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	83.12	10.10	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	82.97	22.04	6.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	93.14	22.80	7.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	82.98	10.69	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	95.89	15.51	8.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	103.75	15.14	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	69.26	5.57	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	72.03	10.19	5.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	87.73	17.87	6.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	78.81	20.59	4.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	102.67	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	118.95	17.06	4.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	104.63	20.33	7.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	98.51	17.36	4.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	100.68	19.21	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	103.32	18.25	7.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	121.69	21.10	5.20
Adipocyte - breast, donor1	11376-118A8	130.35	22.33	4.28
Adipocyte - breast, donor2	11327-117E4	88.23	19.09	5.61
Adipocyte - omental, donor1	11473-119C6	154.20	30.79	3.69
Adipocyte - omental, donor2	11474-119C7	133.80	16.44	11.96
Adipocyte - omental, donor3	11475-119C8	140.00	23.11	8.71
Adipocyte - perirenal, donor1	11476-119C9	161.41	24.24	12.12
Adipocyte - subcutaneous, donor1	11259-116F8	63.77	4.40	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	94.39	12.19	4.97
Adipocyte - subcutaneous, donor3	11408-118E4	62.39	9.38	5.21
Adipocyte differentiation, day04, donor1	13019-139D4	168.19	28.55	9.58
Adipocyte differentiation, day04, donor2	13022-139D7	83.13	15.19	2.57
Adipocyte differentiation, day04, donor3	13025-139E1	104.82	20.91	3.62
Adipocyte differentiation, day04, donor4	13028-139E4	71.13	27.04	4.70
Adipocyte differentiation, day08, donor1	13020-139D5	103.52	31.13	15.36
Adipocyte differentiation, day08, donor2	13023-139D8	68.75	23.24	3.23
Adipocyte differentiation, day08, donor3	13026-139E2	47.45	13.86	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	66.77	21.70	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	68.21	26.20	7.07
Adipocyte differentiation, day12, donor2	13024-139D9	72.84	16.83	4.52
Adipocyte differentiation, day12, donor3	13027-139E3	65.12	17.67	5.56
Adipocyte differentiation, day12, donor4	13030-139E6	36.23	16.75	3.35
Alveolar Epithelial Cells, donor1	11510-119G7	69.17	12.15	6.63
Alveolar Epithelial Cells, donor2	11590-120G6	12.19	3.59	4.30
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	5.99	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	97.51	30.76	9.89
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	18.41	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	60.40	30.61	7.60
Anulus Pulposus Cell, donor1	11248-116E6	112.82	13.39	2.29
Anulus Pulposus Cell, donor2	11463-119B5	90.62	13.96	6.12
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	94.80	15.28	3.59
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	124.16	16.06	5.21
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	62.07	10.70	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	92.37	14.35	4.48
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	115.08	10.12	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	62.05	12.54	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	86.42	13.00	2.92
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	122.33	20.87	8.25
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	67.11	12.47	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	106.21	14.69	7.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	125.54	18.14	9.43
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	72.72	11.28	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	110.21	18.12	3.79
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	102.36	20.47	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	91.23	17.79	4.37
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	105.01	12.32	4.29
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	91.07	14.74	6.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	73.77	16.30	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	97.55	14.63	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	108.14	17.08	5.97
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	55.23	21.61	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	113.28	24.78	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	111.67	17.50	8.58
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	125.73	16.50	6.31
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	121.42	15.56	5.31
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	60.57	10.90	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	104.89	17.67	4.56
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	111.80	15.61	6.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	65.81	12.90	2.06
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	113.08	13.61	5.16
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	103.86	16.72	4.18
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	64.21	10.70	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	89.50	13.45	5.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	102.97	15.96	6.02
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	67.72	14.26	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	105.78	11.19	5.59
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	93.22	13.24	3.82
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	74.34	8.90	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	111.77	15.54	2.59
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	115.79	14.61	4.66
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	75.69	11.31	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	128.48	23.62	4.72
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	111.38	16.44	6.10
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	78.76	20.85	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	105.63	21.13	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	112.57	18.01	6.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	74.00	11.43	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	107.89	18.22	5.83
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	115.17	12.41	6.67
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	53.56	12.75	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	93.05	25.17	4.07
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	120.97	21.47	6.19
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	69.77	15.30	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	110.42	21.51	3.82
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	114.64	17.07	3.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	93.07	13.73	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	103.02	16.62	5.54
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	108.30	15.09	5.83
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	72.33	13.81	5.09
Astrocyte - cerebellum, donor1	11500-119F6	89.90	19.53	5.53
Astrocyte - cerebellum, donor2	11580-120F5	49.12	10.78	3.59
Astrocyte - cerebellum, donor3	11661-122F5	32.51	7.55	2.10
Astrocyte - cerebral cortex, donor1	11235-116D2	117.47	26.14	8.02
Astrocyte - cerebral cortex, donor2	11316-117D2	103.86	20.55	5.66
Astrocyte - cerebral cortex, donor3	11392-118C6	130.07	25.21	10.74
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	91.52	8.37	5.05
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	98.10	9.40	4.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	84.32	7.28	4.67
Basophils, donor1	12241-129G9	60.41	6.28	1.57
Basophils, donor2	12242-129H1	90.56	9.74	0.72
Basophils, donor3	12243-129H2	92.02	13.67	4.85
Bronchial Epithelial Cell, donor1	11511-119G8	43.98	20.27	4.53
Bronchial Epithelial Cell, donor2	11591-120G7	14.63	4.11	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	28.69	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	32.64	10.67	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	45.54	12.27	3.33
Bronchial Epithelial Cell, donor6	11461-119B3	52.28	10.36	3.22
Bronchial Epithelial Cell, donor7	11769-123I5	64.96	14.40	2.88
Burkitt's lymphoma cell line:DAUDI	10422-106C8	100.48	4.33	1.75
Burkitt's lymphoma cell line:RAJI	10476-106I8	173.05	14.44	6.75
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	121.83	23.02	6.08
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	10.34	10.34
CD14+ Monocytes, donor1	11224-116B9	74.95	12.96	2.82
CD14+ Monocytes, donor2	11305-117B9	61.81	7.98	2.04
CD14+ Monocytes, donor3	11381-118B4	63.45	10.54	3.29
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	122.56	29.44	3.40
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	106.14	22.74	6.82
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	100.59	28.60	5.26
CD14+ monocytes - mock treated, donor1	11863-125A9	46.26	4.77	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	40.74	3.32	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	39.09	8.53	1.66
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	33.98	5.86	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.02	3.86	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	48.59	5.21	2.48
CD14+ monocytes - treated with BCG, donor1	11860-125A6	39.55	4.90	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	28.67	5.52	1.42
CD14+ monocytes - treated with BCG, donor3	11880-125C8	60.28	6.75	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	33.48	4.68	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	34.85	3.70	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	47.70	3.33	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	42.39	5.21	2.08
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	35.92	3.99	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	54.76	7.70	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	45.76	6.18	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	32.57	4.75	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	37.54	6.11	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	28.24	6.46	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	44.66	8.03	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	56.81	6.31	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	44.09	5.14	1.84
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.72	3.52	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	39.49	4.39	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	35.40	6.10	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	40.14	7.06	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	62.08	7.11	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	48.32	8.19	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	32.92	3.94	1.62
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	48.25	4.41	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	75.85	9.15	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	76.46	8.32	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	82.75	9.10	1.95
CD14+CD16- Monocytes, donor1	11788-124B6	98.10	10.90	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	84.35	12.05	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	66.89	11.37	1.56
CD14-CD16+ Monocytes, donor1	11790-124B8	61.24	7.66	1.79
CD14-CD16+ Monocytes, donor2	11800-124C9	64.99	8.56	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	74.53	9.26	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	93.49	6.10	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	80.00	7.46	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	79.74	11.39	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	100.21	10.13	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	97.03	11.26	3.75
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	89.85	7.02	2.11
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	94.12	3.92	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	102.83	9.23	5.27
CD19+ B Cells, donor1	11544-120B5	67.40	9.86	3.29
CD19+ B Cells, donor2	11624-122B4	69.64	6.53	1.45
CD19+ B Cells, donor3	11705-123B4	62.09	6.56	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	98.59	20.61	2.83
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	75.50	15.18	2.80
CD34+ Progenitors, donor1	11545-120B6	51.21	7.03	0.00
CD34+ Progenitors, donor2	11625-122B5	62.92	7.87	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	174.73	30.06	10.90
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	169.34	20.97	11.05
CD4+ T Cells, donor1	11225-116C1	95.69	5.36	1.43
CD4+ T Cells, donor2	11306-117C1	64.91	3.06	0.00
CD4+ T Cells, donor3	11382-118B5	76.55	5.18	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	110.77	4.59	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	89.39	5.17	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	78.48	4.89	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	103.83	1.90	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	102.54	4.21	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	105.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	134.69	7.95	2.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	85.24	9.15	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	88.02	5.64	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	86.97	7.62	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	114.60	5.94	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	95.48	5.28	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	114.26	6.32	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	84.15	6.23	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	85.87	6.68	2.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	99.53	5.71	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	124.88	5.36	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	118.35	5.38	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	127.02	10.38	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	119.36	11.26	4.98
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	122.94	9.88	2.31
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	93.03	6.57	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	105.28	6.93	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	114.18	4.36	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	126.19	9.90	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	119.09	7.39	5.54
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	127.02	5.58	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	135.70	7.75	4.15
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	160.24	8.10	3.93
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	118.58	4.62	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	115.67	6.80	2.86
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	95.56	5.54	4.15
CD8+ T Cells, donor1	11226-116C2	121.46	6.55	2.29
CD8+ T Cells, donor2	11307-117C2	82.60	6.38	1.88
CD8+ T Cells, donor3	11383-118B6	84.84	5.30	2.52
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	88.09	10.55	3.90
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	68.06	9.35	3.59
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	73.05	10.40	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	102.67	6.90	5.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	74.39	12.72	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	58.89	10.00	4.55
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	74.96	11.08	5.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	73.70	9.48	2.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	82.08	10.08	3.99
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	98.71	13.89	6.04
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	75.24	16.85	4.36
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	97.78	12.26	7.19
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	51.65	9.63	4.38
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	51.01	10.02	5.92
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.80	15.66	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	75.99	9.00	5.04
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	81.14	9.49	3.74
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	55.15	8.25	3.30
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	87.47	10.46	7.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	75.35	11.07	5.84
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	80.15	8.98	4.81
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	99.06	14.53	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	87.10	12.61	4.34
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	66.56	12.10	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	8.03	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	4.90	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	43.08	10.02	2.00
Cardiac Myocyte, donor1	11525-119I4	54.83	12.79	0.00
Cardiac Myocyte, donor2	11605-120I3	120.56	20.26	5.43
Cardiac Myocyte, donor3	11686-122I3	162.27	21.15	11.68
Chondrocyte - de diff, donor1	11261-116G1	162.59	36.75	11.79
Chondrocyte - de diff, donor2	11338-117F6	55.79	16.35	1.78
Chondrocyte - de diff, donor3	11410-118E6	96.37	23.55	6.83
Chondrocyte - re diff, donor2	11339-117F7	181.74	23.28	5.37
Chondrocyte - re diff, donor3	11411-118E7	149.22	23.46	7.68
Ciliary Epithelial Cells, donor1	11242-116D9	98.12	19.28	3.33
Ciliary Epithelial Cells, donor2	11323-117D9	82.30	17.53	3.85
Ciliary Epithelial Cells, donor3	11399-118D4	108.32	17.79	5.40
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	92.07	21.00	5.50
Corneal Epithelial Cells, donor1	11526-119I5	28.76	11.42	3.73
Corneal Epithelial Cells, donor2	11606-120I4	45.50	19.34	1.14
Corneal Epithelial Cells, donor3	11687-122I4	39.62	12.27	2.56
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	63.07	18.33	3.63
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	74.44	18.61	5.68
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	69.01	13.80	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	72.25	16.09	5.72
Dendritic Cells - plasmacytoid, donor1	11228-116C4	249.40	14.35	4.78
Dendritic Cells - plasmacytoid, donor2	11309-117C4	315.34	23.50	3.26
Dendritic Cells - plasmacytoid, donor3	11385-118B8	316.98	17.42	7.26
Endothelial Cells - Aortic, donor0	11207-116A1	54.20	11.34	6.34
Endothelial Cells - Aortic, donor1	11263-116G3	64.55	16.43	5.28
Endothelial Cells - Aortic, donor2	11340-117F8	60.24	14.99	5.66
Endothelial Cells - Aortic, donor3	11412-118E8	40.10	8.26	3.15
Endothelial Cells - Artery, donor1	11264-116G4	80.28	17.45	10.18
Endothelial Cells - Artery, donor2	11341-117F9	112.46	16.70	8.23
Endothelial Cells - Artery, donor3	11413-118E9	74.68	12.45	5.79
Endothelial Cells - Lymphatic, donor1	11236-116D3	81.57	17.51	7.76
Endothelial Cells - Lymphatic, donor2	11317-117D3	112.27	24.04	7.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	141.23	22.83	6.20
Endothelial Cells - Microvascular, donor1	11265-116G5	96.87	13.07	4.16
Endothelial Cells - Microvascular, donor2	11342-117G1	66.65	8.33	2.60
Endothelial Cells - Microvascular, donor3	11414-118F1	51.89	8.08	4.68
Endothelial Cells - Thoracic, donor1	11266-116G6	154.45	19.21	7.60
Endothelial Cells - Thoracic, donor2	11343-117G2	91.72	18.34	3.67
Endothelial Cells - Umbilical vein, donor1	11243-116E1	143.50	19.63	9.32
Endothelial Cells - Umbilical vein, donor2	11324-117E1	57.79	14.99	5.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	67.17	14.66	7.21
Endothelial Cells - Vein, donor1	11267-116G7	70.53	7.96	6.83
Endothelial Cells - Vein, donor2	11344-117G3	69.85	14.67	2.10
Endothelial Cells - Vein, donor3	11416-118F3	64.37	13.03	6.59
Eosinophils, donor1	12244-129H3	121.98	15.25	0.00
Eosinophils, donor2	12245-129H4	14.85	1.65	0.00
Eosinophils, donor3	12246-129H5	14.27	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	38.85	12.22	5.13
Esophageal Epithelial Cells, donor2	11587-120G3	33.28	14.56	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	65.08	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	140.40	25.86	5.75
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	71.61	17.41	5.69
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.28	4.77	0.98
Fibroblast - Aortic Adventitial, donor1	11245-116E3	166.03	21.71	6.31
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	216.17	29.07	11.46
Fibroblast - Aortic Adventitial, donor2	11326-117E3	121.92	24.57	6.33
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	563.61	60.34	16.34
Fibroblast - Aortic Adventitial, donor3	11401-118D6	121.59	20.26	9.63
Fibroblast - Cardiac, donor1	11268-116G8	69.86	14.97	9.07
Fibroblast - Cardiac, donor2	11345-117G4	74.28	12.13	3.79
Fibroblast - Cardiac, donor3	11417-118F4	100.31	17.19	7.25
Fibroblast - Cardiac, donor4	11452-119A3	121.24	25.76	4.85
Fibroblast - Cardiac, donor5	11456-119A7	115.23	21.19	6.47
Fibroblast - Cardiac, donor6	11460-119B2	113.09	19.25	6.22
Fibroblast - Choroid Plexus, donor1	11492-119E7	150.07	28.94	8.71
Fibroblast - Choroid Plexus, donor2	11572-120E6	63.42	18.12	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	166.99	20.51	8.79
Fibroblast - Conjunctival, donor1	11531-120A1	86.95	16.84	4.84
Fibroblast - Conjunctival, donor3	11692-122I9	83.28	19.33	2.71
Fibroblast - Dermal, donor1	11269-116G9	71.37	10.33	2.11
Fibroblast - Dermal, donor2	11346-117G5	48.58	11.79	2.36
Fibroblast - Dermal, donor3	11418-118F5	72.41	11.73	3.02
Fibroblast - Dermal, donor4	11450-119A1	98.58	13.23	4.75
Fibroblast - Dermal, donor5	11454-119A5	103.80	12.21	6.63
Fibroblast - Dermal, donor6	11458-119A9	116.62	14.94	6.50
Fibroblast - Gingival, donor1	11237-116D4	129.31	14.16	4.16
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	76.24	15.72	4.45
Fibroblast - Gingival, donor2	11318-117D4	91.33	11.07	3.69
Fibroblast - Gingival, donor3	11394-118C8	92.82	14.60	4.35
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	134.02	15.58	8.31
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	75.06	14.98	3.52
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	71.40	14.03	5.77
Fibroblast - Gingival, donor6 (control)	11922-125H5	76.94	12.71	2.84
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	43.05	16.94	3.18
Fibroblast - Gingival, donor7 (control)	11924-125H7	69.32	17.40	4.83
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	68.99	16.77	2.32
Fibroblast - Gingival, donor8 (control)	11926-125H9	73.38	15.69	4.72
Fibroblast - Gingival, donor9 (control)	11927-125I1	69.85	16.29	3.82
Fibroblast - Lung, donor1	11270-116H1	48.94	10.87	1.36
Fibroblast - Lung, donor2	11347-117G6	88.04	4.48	1.49
Fibroblast - Lung, donor3	11419-118F6	79.56	13.08	3.59
Fibroblast - Lymphatic, donor1	11506-119G3	94.13	27.49	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	92.31	15.38	6.99
Fibroblast - Lymphatic, donor3	11667-122G2	12.03	3.64	1.40
Fibroblast - Mammary, donor1	11540-120B1	182.69	29.23	6.90
Fibroblast - Mammary, donor2	11620-122A9	27.96	11.98	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	35.74	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	117.55	9.12	5.24
Fibroblast - Periodontal Ligament, donor2	11319-117D5	120.28	16.23	4.55
Fibroblast - Periodontal Ligament, donor3	11395-118C9	168.91	26.31	9.79
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	77.85	16.41	6.49
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	80.46	17.28	4.59
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	87.79	23.19	7.54
Fibroblast - Pulmonary Artery, donor1	11250-116E8	141.04	17.80	6.96
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	95.91	27.02	8.74
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	54.12	10.02	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	75.51	10.67	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	261.36	26.39	6.35
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	163.05	25.22	7.99
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	132.44	24.24	4.34
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	399.23	37.31	15.04
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	175.31	19.86	8.96
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	233.84	24.04	6.07
Fibroblast - skin normal, donor1	11553-120C5	178.02	26.74	7.22
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	407.03	45.72	19.45
Fibroblast - skin normal, donor2	11561-120D4	196.70	21.50	6.33
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	239.37	19.65	7.56
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	96.68	16.24	2.57
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	91.80	21.54	4.44
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	485.09	48.61	13.79
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	203.99	25.46	9.48
Fibroblast - skin walker warburg, donor1	11554-120C6	155.02	21.59	6.75
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	136.59	10.35	4.86
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	25.27	15.69	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	51.14	15.95	4.16
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	105.40	15.61	7.29
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	58.00	10.99	6.13
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	93.40	35.98	5.36
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	94.43	27.44	7.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	114.68	29.67	9.98
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	101.48	38.33	15.72
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	82.88	20.78	7.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	104.41	30.12	13.67
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	102.30	35.69	15.60
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	62.95	28.37	11.09
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.92	29.63	10.61
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	91.44	23.88	5.94
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	77.09	16.25	7.76
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	91.60	23.37	5.91
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	73.72	10.16	3.84
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	78.21	14.40	4.29
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	64.24	14.84	2.85
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	81.46	12.55	3.88
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	70.13	11.34	4.48
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	67.10	18.14	3.72
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	72.69	12.11	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	78.84	12.88	4.45
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	98.30	20.55	4.92
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	82.06	12.50	3.83
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	81.09	13.74	2.71
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	127.24	21.10	3.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	94.17	15.40	3.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	105.03	17.08	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	78.79	13.17	2.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	115.89	20.80	3.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	126.59	18.78	4.29
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	64.99	13.62	3.30
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	75.17	12.34	2.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	78.55	11.01	4.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	59.52	8.82	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	77.73	12.42	3.32
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	64.35	15.72	4.05
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	59.65	8.66	3.53
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	72.30	10.42	4.83
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	69.28	10.76	3.64
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	72.37	9.73	3.34
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	77.57	10.14	3.14
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	62.79	12.95	3.51
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	69.58	12.91	3.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	66.76	10.09	2.59
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	77.28	12.84	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	75.43	11.17	2.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	76.82	11.79	2.59
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	87.83	11.93	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	73.74	11.43	2.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	68.86	10.75	4.17
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	66.45	5.95	4.96
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	79.54	12.66	3.03
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	76.47	10.69	3.63
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	99.63	16.27	3.05
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	163.43	29.06	10.95
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	91.98	22.03	6.16
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	103.11	25.16	7.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	112.34	29.42	9.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	104.55	25.43	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	107.46	23.98	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	86.62	27.22	14.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	105.99	29.40	7.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	97.87	27.28	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	92.16	20.87	10.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	95.04	25.06	6.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	82.77	22.65	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	106.63	19.99	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	95.64	26.57	4.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	108.84	25.17	5.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	95.63	21.81	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	91.92	21.31	6.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	86.61	21.74	6.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	89.79	14.62	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	92.20	17.75	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	83.47	17.17	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	77.93	18.64	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	97.75	16.57	7.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	110.23	23.70	7.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	100.10	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	78.04	17.68	7.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	94.21	17.93	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	74.24	17.39	6.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	71.27	17.72	2.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	116.40	19.86	5.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	17.39	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	74.55	19.82	8.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	77.25	15.69	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	81.39	13.73	7.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	98.51	15.95	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	83.87	13.32	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	62.56	15.35	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	71.18	14.00	5.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	78.56	13.61	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	70.36	8.48	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	88.94	13.73	5.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	83.95	14.56	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	81.03	11.41	7.99
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	75.26	13.72	3.74
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	2.25	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.04	13.32	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	56.40	7.94	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	117.32	23.90	9.40
Hep-2 cells mock treated, biol_rep2	11899-125E9	108.03	21.78	6.92
Hep-2 cells mock treated, biol_rep3	11900-125F1	115.34	17.97	7.96
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	112.81	23.83	9.18
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	140.77	24.93	9.67
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	119.27	20.67	7.97
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	110.96	25.28	9.09
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	113.74	20.76	7.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	91.95	21.79	8.65
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	69.39	19.59	6.72
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.48	9.52	3.03
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	66.10	26.44	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	83.24	29.63	6.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	31.97	7.99	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	130.43	17.66	7.34
Hepatocyte, donor1	11523-119I2	110.16	29.05	3.63
Hepatocyte, donor2	11603-120I1	105.58	45.25	9.70
Hepatocyte, donor3	11684-122I1	115.35	31.90	11.66
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	150.77	22.19	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	331.56	69.74	22.90
Iris Pigment Epithelial Cells, donor1	11530-119I9	132.68	22.78	8.64
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	12.74	9.55
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	26.70	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	67.83	19.38	13.84
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	67.57	12.51	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	30.75	17.94
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	91.42	22.85	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	84.47	22.74	8.12
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	70.03	18.34	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	18.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	67.50	18.53	7.94
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	53.21	14.41	11.09
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	78.57	26.19	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	59.84	10.71	6.30
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	74.24	18.56	10.83
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	67.83	16.15	5.81
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	69.23	16.10	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	66.01	24.45	10.59
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	73.05	18.89	6.72
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	65.90	23.31	12.06
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	70.17	16.62	8.31
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	135.73	30.16	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	80.72	14.63	7.08
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	69.84	19.05	7.26
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	147.42	14.74	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	82.86	31.21	7.53
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	85.12	31.76	12.70
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	65.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	65.04	17.86	5.74
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	80.20	23.69	10.94
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	64.27	15.71	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	49.77	23.23	13.27
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	63.89	17.28	7.41
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	73.75	15.80	7.02
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	28.29	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	55.63	20.17	5.56
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	59.75	19.92	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	119.95	12.97	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	60.16	7.85	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	38.25	18.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	90.60	24.39	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	55.47	12.80	6.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	56.80	8.31	9.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	79.79	22.80	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	58.91	17.49	6.44
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	12.10	12.10
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	51.81	5.29	4.23
Keratinocyte - epidermal, donor1	11272-116H3	54.43	12.16	1.88
Keratinocyte - epidermal, donor2	11349-117G8	42.17	6.44	2.34
Keratinocyte - epidermal, donor3	11421-118F8	60.39	12.68	3.79
Keratinocyte - oral, donor1	11251-116E9	104.10	11.69	2.61
Keratocytes, donor1	11527-119I6	100.05	14.44	5.50
Keratocytes, donor2	11607-120I5	37.50	7.03	2.34
Keratocytes, donor3	11688-122I5	64.42	8.50	3.16
Krukenberg tumor cell line:HSKTC	10687-109F3	123.08	50.55	8.79
Lens Epithelial Cells, donor1	11529-119I8	107.87	17.26	6.47
Lens Epithelial Cells, donor2	11609-120I7	119.02	17.65	7.27
Lens Epithelial Cells, donor3	11690-122I7	168.72	36.13	10.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	81.11	11.62	4.15
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	64.19	7.81	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	82.48	12.59	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	55.38	5.38	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	46.64	10.09	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	60.70	10.67	2.48
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	59.92	8.62	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	51.07	9.86	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	65.31	9.57	1.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	46.67	5.14	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	72.90	6.98	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	58.32	6.67	2.41
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	65.50	11.15	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	65.83	8.35	1.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	63.32	10.58	2.47
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	60.36	7.70	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	51.13	8.73	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	71.55	12.99	3.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	68.46	9.54	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	44.22	6.44	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	58.75	7.47	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	66.92	8.73	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	62.75	6.19	2.69
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	63.88	10.90	2.72
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	58.06	6.74	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	65.33	6.28	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	61.35	9.77	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	58.47	8.25	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	45.91	5.46	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	53.01	7.74	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	69.78	5.81	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	52.93	4.96	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	74.34	10.41	3.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	60.71	10.37	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	63.99	3.71	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	64.48	8.25	2.47
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	63.04	7.40	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	62.08	7.30	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	83.70	10.78	3.50
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	73.96	9.96	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	46.54	5.33	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	61.15	8.09	2.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	67.68	8.95	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	65.33	2.94	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	57.21	8.95	2.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	84.77	8.54	3.34
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	43.29	5.38	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	60.57	5.37	2.98
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	15.86	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	34.52	16.88	7.67
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	47.50	14.10	7.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	38.93	20.31	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	50.64	14.07	4.92
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	50.43	14.94	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	30.92	10.82	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	35.68	8.33	7.14
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	45.46	15.15	2.71
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	45.95	18.32	2.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	49.97	20.71	4.95
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	52.97	15.72	3.25
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	41.60	14.38	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	67.75	22.23	8.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	50.64	12.66	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	47.37	15.79	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	60.03	20.54	6.14
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	55.93	19.27	5.29
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	35.59	16.57	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	43.22	18.75	7.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	53.10	17.28	6.46
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	50.45	19.34	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	36.06	17.52	14.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	56.03	16.26	5.81
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	51.42	17.34	4.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	69.71	20.47	6.64
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	41.36	21.56	4.95
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	51.63	22.13	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	10.36	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	45.67	17.27	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	35.10	8.49	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	42.66	16.41	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	42.48	14.01	3.62
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	47.40	11.49	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	51.54	17.93	11.20
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	49.42	17.09	4.83
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	56.86	13.35	4.31
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	50.52	16.27	5.99
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	48.64	15.99	3.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	36.80	12.07	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	50.48	9.24	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	42.96	18.22	2.75
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	30.06	17.71	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	44.44	9.43	6.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	40.00	12.22	2.59
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	30.24	8.14	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	43.37	13.75	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	55.62	19.61	6.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	28.35	17.44	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	53.66	21.46	5.37
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	32.06	12.83	4.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	4.70	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	46.76	16.59	5.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	41.01	15.32	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	10.33	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	54.33	16.92	6.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	39.49	16.42	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.97	12.53	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	55.53	15.05	5.19
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	46.38	20.57	4.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	46.96	18.45	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	51.67	23.41	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	43.59	16.59	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	38.99	11.65	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	54.31	13.46	4.33
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	47.31	9.54	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.89	13.98	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.89	16.60	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	47.50	13.68	4.18
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	27.37	17.04	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	55.02	16.93	3.02
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	49.12	18.06	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	28.25	10.66	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.05	11.49	6.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.97	10.80	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.25	14.15	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	41.43	15.89	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	42.43	13.31	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	13.31	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	45.10	14.61	5.43
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	34.38	13.94	4.65
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	31.45	12.71	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	52.39	12.83	6.95
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	41.62	16.16	5.25
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	34.87	14.68	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	49.79	12.45	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	35.33	15.39	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	38.34	13.80	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	47.60	16.96	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	41.87	16.93	6.68
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	44.71	15.86	5.46
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	40.45	11.27	4.64
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	20.79	2.08
Macrophage - monocyte derived, donor1	11232-116C8	115.10	17.09	3.87
Macrophage - monocyte derived, donor2	11313-117C8	122.22	17.43	5.51
Macrophage - monocyte derived, donor3	11389-118C3	90.71	19.79	5.24
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	70.09	12.21	4.78
Mallassez-derived cells, donor2	11929-125I3	125.34	21.71	5.70
Mallassez-derived cells, donor3	11930-125I4	96.46	12.79	2.64
Mammary Epithelial Cell, donor1	11273-116H4	118.18	19.93	5.58
Mammary Epithelial Cell, donor2	11350-117G9	100.76	18.53	5.50
Mammary Epithelial Cell, donor3	11422-118F9	46.14	15.22	3.99
Mast cell - stimulated, donor1	11487-119E2	161.35	12.88	2.03
Mast cell, donor1	11563-120D6	106.84	10.06	2.16
Mast cell, donor2	11565-120D8	62.70	7.73	4.16
Mast cell, donor3	11566-120D9	65.96	7.88	1.35
Mast cell, donor4	11567-120E1	46.63	7.27	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	233.32	22.73	3.55
Mast cell, expanded and stimulated, donor8	11942-126A7	92.22	11.67	1.17
Mast cell, expanded, donor5	11939-126A4	106.35	9.41	1.26
Mast cell, expanded, donor8	11941-126A6	74.31	10.88	1.17
Melanocyte - dark, donor1	11502-119F8	107.66	17.11	6.77
Melanocyte - dark, donor2	11582-120F7	125.63	16.96	4.85
Melanocyte - dark, donor3	11663-122F7	142.35	19.92	4.20
Melanocyte - light, donor1	11274-116H5	43.02	11.75	2.12
Melanocyte - light, donor2	11351-117H1	55.96	8.19	0.68
Melanocyte - light, donor3	11423-118G1	46.83	4.34	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	78.41	10.52	4.06
Melanocyte, donor2 (MC+2)	12739-135I3	78.80	15.60	2.69
Melanocyte, donor3 (MC+3)	12837-137B2	108.48	15.54	4.29
Meningeal Cells, donor1	11493-119E8	158.05	23.45	7.44
Meningeal Cells, donor2	11573-120E7	187.06	27.73	15.41
Meningeal Cells, donor3	11654-122E7	130.16	16.87	3.18
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	116.06	11.98	5.99
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	159.80	29.49	6.04
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	5.26	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	15.70	6.54	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	86.83	10.05	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	126.85	20.75	5.08
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	80.42	19.10	3.02
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	72.52	10.99	3.30
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	63.56	13.15	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	46.85	8.39	4.09
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	141.83	12.74	4.02
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	31.97	11.52	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	150.39	19.87	5.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	47.18	13.95	2.67
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	79.41	10.25	5.76
Mesenchymal stem cells - adipose, donor0	11217-116B2	157.37	11.70	2.84
Mesenchymal stem cells - hepatic, donor0	11218-116B3	175.44	15.64	7.82
Mesenchymal stem cells - umbilical, donor0	11214-116A8	127.72	15.24	5.81
Mesothelial Cells, donor1	11247-116E5	142.93	25.19	8.22
Mesothelial Cells, donor2	12156-128G5	85.08	26.02	9.01
Mesothelial Cells, donor3	11402-118D7	81.51	19.58	5.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	14.85	5.40	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	64.28	16.99	5.42
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	50.06	15.02	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	10.37	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	59.82	12.09	4.65
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	52.07	12.24	3.53
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	72.83	14.77	3.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.72	17.22	3.72
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	55.88	11.79	3.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	37.62	15.44	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	55.75	5.31	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	62.31	15.58	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	5.26	9.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	66.85	13.37	3.61
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	14.73	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	41.73	10.13	4.47
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	5.03	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	54.95	9.28	4.01
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	40.17	15.69	2.14
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.82	3.87	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	55.26	9.67	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	44.17	10.94	2.31
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	42.19	8.15	2.24
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	61.36	10.30	3.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	30.90	10.00	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	44.68	9.86	2.63
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	17.74	13.18	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	9.94	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.79	10.33	4.89
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	32.94	12.94	2.06
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	5.45	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	60.07	12.97	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	38.02	9.61	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	4.11	4.11
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	56.06	13.02	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	53.89	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	6.12	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	59.56	12.70	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	6.62	8.83
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	4.48	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	60.24	8.43	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	14.61	11.13	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	65.98	11.97	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.50	9.19	3.94
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	15.27	7.10	2.84
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	68.45	10.94	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.44	7.07	2.49
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	14.57	8.16	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	41.33	8.45	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	35.48	12.94	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	5.54	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	31.87	19.35	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	28.47	4.42	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	54.94	11.14	3.89
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	40.75	14.59	4.72
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	5.08	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	24.29	5.07	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	63.76	12.57	2.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.58	6.07	1.98
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	67.84	7.01	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	50.64	16.36	4.64
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	23.89	5.69	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	50.85	7.10	3.13
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	75.95	14.75	3.93
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	22.81	5.87	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	47.04	10.00	2.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	59.11	19.03	6.63
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.98	7.42	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	53.01	7.74	2.08
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	67.80	15.07	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	60.60	14.26	7.13
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	91.67	14.79	3.61
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	65.22	15.78	4.21
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	57.13	19.57	3.56
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	20.49	9.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	60.08	17.27	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	58.33	13.85	4.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	63.56	15.16	2.04
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	57.46	12.52	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	76.58	17.59	4.03
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	49.78	7.78	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	65.74	14.96	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	19.32	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	67.67	13.13	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	51.44	7.59	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	53.12	6.81	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	27.34	3.18	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	37.25	10.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	37.76	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	17.13	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	48.94	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	19.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	139.17	24.34	7.97
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	88.84	17.25	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	63.41	14.02	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	36.31	17.95	5.84
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	63.13	18.82	7.80
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	76.60	33.51	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	57.80	20.40	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	3.68	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	61.52	18.42	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	57.41	23.01	9.30
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	57.83	24.59	3.24
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	51.51	22.92	2.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	74.95	15.39	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	49.26	11.91	3.52
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	63.70	19.95	4.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	34.29	15.19	2.78
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	57.23	18.04	3.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	58.88	20.69	3.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	48.02	18.61	3.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	43.98	7.55	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	46.51	15.61	5.04
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	42.68	16.58	3.70
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	53.45	11.25	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.97	17.47	3.22
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	68.77	22.82	7.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	54.49	10.00	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	25.28	7.59	15.17
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	39.21	17.60	3.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	40.65	18.63	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	36.79	13.29	3.80
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	88.85	24.90	8.58
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	58.98	19.33	6.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	28.86	25.25	3.16
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	51.58	16.27	3.57
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	86.36	16.72	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	68.11	18.92	7.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	58.66	28.35	2.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	25.71	13.51	3.49
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	44.78	17.19	4.98
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	75.84	15.87	5.29
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	61.17	11.97	5.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	71.43	13.39	5.95
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	52.83	21.82	8.42
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	97.39	19.36	6.35
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	53.05	19.67	5.97
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	58.96	14.23	3.39
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	25.55	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	74.99	25.00	4.27
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	40.29	24.55	5.04
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	41.16	13.92	3.93
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	71.99	19.78	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	7.94	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	45.52	0.00	0.00
Myoblast, donor1	11241-116D8	122.12	15.16	7.33
Myoblast, donor2	11322-117D8	116.03	23.40	4.22
Myoblast, donor3	11398-118D3	118.72	24.38	8.74
NK T cell leukemia cell line:KHYG-1	10777-110G3	143.89	10.94	6.13
Natural Killer Cells, donor1	11230-116C6	114.70	8.92	3.38
Natural Killer Cells, donor2	11311-117C6	78.71	4.22	2.41
Natural Killer Cells, donor3	11387-118C1	92.03	6.99	3.13
Neural stem cells, donor1	11275-116H6	96.18	25.77	1.09
Neural stem cells, donor2	11352-117H2	125.17	23.11	5.78
Neurons, donor1	11494-119E9	99.00	25.03	1.14
Neurons, donor2	11574-120E8	90.93	22.46	2.20
Neurons, donor3	11655-122E8	63.31	24.66	3.29
Neutrophils, donor1	11233-116C9	15.78	0.93	0.00
Neutrophils, donor2	11314-117C9	26.09	2.90	0.00
Neutrophils, donor3	11390-118C4	26.88	6.11	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	66.61	9.50	3.21
Nucleus Pulposus Cell, donor2	11409-118E5	51.12	14.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	78.82	9.83	4.41
Olfactory epithelial cells, donor1	11933-125I7	52.72	12.53	1.93
Olfactory epithelial cells, donor2	11934-125I8	66.29	17.95	4.05
Olfactory epithelial cells, donor3	11935-125I9	60.50	17.37	2.95
Olfactory epithelial cells, donor4	11936-126A1	55.32	17.34	2.92
Oligodendrocyte - precursors, donor1	11496-119F2	115.55	17.45	6.62
Osteoblast - differentiated, donor1	11276-116H7	52.32	15.74	3.62
Osteoblast - differentiated, donor2	11353-117H3	32.01	13.72	4.57
Osteoblast - differentiated, donor3	11425-118G3	52.76	11.79	3.10
Osteoblast, donor1	11277-116H8	58.24	11.73	3.91
Osteoblast, donor2	11354-117H4	162.94	23.18	5.62
Osteoblast, donor3	11426-118G4	51.36	13.51	5.69
Pancreatic stromal cells, donor1	11249-116E7	125.68	16.34	5.90
Pericytes, donor1	11491-119E6	22.92	6.45	2.56
Pericytes, donor2	11571-120E5	25.35	7.24	2.04
Pericytes, donor3	11652-122E5	85.86	22.38	5.90
Perineurial Cells, donor1	11499-119F5	187.39	26.56	10.62
Perineurial Cells, donor2	11579-120F4	169.21	26.41	11.87
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	96.26	9.88	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	49.46	7.59	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	65.35	5.18	2.59
Placental Epithelial Cells, donor1	11278-116H9	51.18	18.42	4.30
Placental Epithelial Cells, donor2	11355-117H5	68.75	18.85	3.33
Placental Epithelial Cells, donor3	11427-118G5	47.31	20.61	9.03
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	109.81	18.67	6.96
Preadipocyte - breast, donor1	11467-119B9	97.36	19.88	1.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	191.09	24.41	9.92
Preadipocyte - breast, donor2	11328-117E5	100.87	20.26	5.40
Preadipocyte - omental, donor1	11468-119C1	133.84	28.02	3.41
Preadipocyte - omental, donor2	11329-117E6	120.03	17.02	6.11
Preadipocyte - omental, donor3	11403-118D8	141.53	28.65	8.31
Preadipocyte - perirenal, donor1	11469-119C2	128.94	21.65	7.87
Preadipocyte - subcutaneous, donor1	11279-116I1	47.91	11.67	4.30
Preadipocyte - subcutaneous, donor2	11356-117H6	119.53	21.60	6.20
Preadipocyte - subcutaneous, donor3	11428-118G6	145.08	28.27	7.83
Preadipocyte - visceral, donor1	11280-116I2	132.27	21.05	4.38
Preadipocyte - visceral, donor2	11357-117H7	80.53	18.87	2.30
Preadipocyte - visceral, donor3	11429-118G7	87.56	16.30	5.33
Prostate Epithelial Cells (polarized), donor1	11253-116F2	321.32	69.54	21.27
Prostate Epithelial Cells, donor2	11331-117E8	50.10	10.83	3.93
Prostate Epithelial Cells, donor3	11404-118D9	59.46	8.70	2.45
Prostate Stromal Cells, donor1	11254-116F3	159.69	20.50	7.18
Prostate Stromal Cells, donor2	11332-117E9	116.19	20.26	6.45
Prostate Stromal Cells, donor3	11405-118E1	97.71	19.08	6.47
Renal Cortical Epithelial Cells, donor1	11516-119H4	43.80	10.22	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	85.18	7.83	1.66
Renal Epithelial Cells, donor1	11517-119H5	20.29	6.59	3.55
Renal Epithelial Cells, donor2	11597-120H4	44.10	14.94	2.13
Renal Epithelial Cells, donor3	11678-122H4	96.23	12.81	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	32.00	14.30	5.45
Renal Glomerular Endothelial Cells, donor2	11594-120H1	75.60	13.88	11.45
Renal Glomerular Endothelial Cells, donor3	11675-122H1	95.02	23.98	8.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	7.99	3.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	55.02	14.31	4.40
Renal Mesangial Cells, donor2	11598-120H5	72.10	11.91	5.64
Renal Mesangial Cells, donor3	11679-122H5	21.08	6.10	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	97.71	17.98	4.03
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	59.46	7.59	3.37
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	53.42	15.04	3.86
Retinal Pigment Epithelial Cells, donor0	11215-116A9	119.79	19.19	7.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	105.74	19.04	3.70
Retinal Pigment Epithelial Cells, donor2	11608-120I6	20.58	5.15	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	71.51	11.79	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	136.04	37.28	6.01
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	47.35	20.55	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	117.23	8.81	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	51.04	11.02	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	69.30	15.60	8.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	56.80	14.10	5.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	97.15	16.84	5.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	103.58	14.51	8.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	73.42	14.80	5.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	68.65	13.87	4.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	63.53	11.91	8.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	56.58	10.89	6.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	68.81	18.64	4.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	80.19	12.48	9.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	61.17	13.09	5.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	65.27	14.38	9.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	56.78	13.96	7.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	51.80	12.48	6.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	77.23	16.72	4.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	56.67	12.34	7.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	50.71	14.31	6.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	73.90	17.00	7.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	64.08	13.46	7.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	50.17	11.21	4.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	40.67	13.16	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	56.16	14.77	8.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	70.76	13.49	5.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	72.26	14.64	7.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	91.99	14.15	5.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	67.06	13.69	6.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	59.16	17.07	5.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	82.32	15.97	6.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	51.76	13.05	2.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	65.80	15.25	7.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	74.02	14.13	8.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	47.85	12.77	4.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	58.03	16.39	7.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	75.65	13.93	6.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	52.12	14.27	7.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	60.25	15.43	4.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	65.79	12.10	8.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	63.33	13.76	9.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	46.65	16.53	5.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	78.67	14.52	5.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	73.57	12.62	7.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	60.87	20.36	7.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	88.90	16.10	8.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	74.76	15.02	6.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	48.35	19.95	5.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	80.78	20.07	9.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	88.06	23.58	4.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	68.75	22.51	9.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	77.16	14.47	12.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	104.27	23.98	7.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	85.97	19.17	6.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	125.75	18.42	9.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	94.77	19.64	9.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	70.31	17.43	7.21
Schwann Cells, donor1	11498-119F4	42.50	9.22	3.95
Schwann Cells, donor2	11578-120F3	78.26	17.01	0.00
Schwann Cells, donor3	11659-122F3	104.50	12.27	4.60
Sebocyte, donor1	11220-116B5	80.52	7.67	7.12
Sebocyte, donor2	11301-117B5	36.30	8.27	0.92
Sebocyte, donor3	11378-118B1	36.69	7.42	2.68
Sertoli Cells, donor1	11255-116F4	245.18	23.19	19.88
Sertoli Cells, donor2	11333-117F1	62.14	16.95	0.00
Skeletal Muscle Cells, donor1	11281-116I3	91.50	10.82	1.58
Skeletal Muscle Cells, donor2	11358-117H8	40.48	10.84	3.61
Skeletal Muscle Cells, donor3	11430-118G8	71.06	11.70	5.02
Skeletal Muscle Cells, donor4	11451-119A2	100.07	11.47	6.13
Skeletal Muscle Cells, donor5	11455-119A6	86.81	15.76	4.31
Skeletal Muscle Cells, donor6	11459-119B1	107.73	13.54	6.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	127.01	12.85	3.91
Skeletal Muscle Satellite Cells, donor2	11321-117D7	85.04	13.13	4.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	101.29	16.47	6.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	95.71	19.04	3.71
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	40.53	5.07	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	64.40	15.27	5.92
Skin - palm, donor1	10286-104F7	24.17	10.74	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	33.59	10.67	5.05
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	63.80	6.54	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	30.77	9.09	2.86
Small Airway Epithelial Cells, donor1	11256-116F5	111.90	18.77	2.50
Small Airway Epithelial Cells, donor2	11334-117F2	57.67	11.25	5.49
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	92.19	16.49	8.88
Small Airway Epithelial Cells, donor3	11406-118E2	81.40	15.29	5.92
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.03	4.32	2.47
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	457.11	64.25	23.57
Smooth Muscle Cells - Aortic, donor0	11210-116A4	61.72	12.93	7.64
Smooth Muscle Cells - Aortic, donor1	11283-116I5	139.45	18.34	2.87
Smooth Muscle Cells - Aortic, donor2	11360-117I1	91.75	15.36	3.54
Smooth Muscle Cells - Aortic, donor3	11432-118H1	68.76	17.00	4.64
Smooth Muscle Cells - Bladder, donor1	11519-119H7	57.04	9.01	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	101.54	15.17	3.86
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	187.30	31.03	9.09
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	66.19	15.75	10.63
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	95.40	11.72	5.86
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	142.64	28.65	7.09
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	94.67	20.64	7.12
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	21.31	6.83	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	42.62	14.61	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	89.15	16.92	4.04
Smooth Muscle Cells - Carotid, donor2	11362-117I3	477.42	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	74.86	12.87	5.25
Smooth Muscle Cells - Colonic, donor1	11239-116D6	102.49	16.96	5.31
Smooth Muscle Cells - Colonic, donor2	11320-117D6	87.82	17.00	3.66
Smooth Muscle Cells - Colonic, donor3	11396-118D1	101.60	16.79	9.87
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	75.95	15.93	5.41
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	39.88	4.31	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	109.38	13.45	4.48
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	37.21	9.56	3.76
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	90.62	12.72	2.51
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	138.78	28.98	3.02
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	217.31	33.45	7.74
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	97.82	11.47	4.23
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	135.38	13.25	9.80
Smooth Muscle Cells - Prostate, donor1	11257-116F6	199.47	28.23	12.65
Smooth Muscle Cells - Prostate, donor2	11335-117F3	150.76	27.42	10.27
Smooth Muscle Cells - Prostate, donor3	11465-119B7	96.90	19.28	1.78
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	124.69	19.90	5.73
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	78.02	13.50	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	351.48	9.05	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	77.67	20.46	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	122.69	20.70	7.07
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	72.39	18.80	6.27
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	46.90	13.57	3.24
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	114.96	17.66	6.91
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	42.04	6.07	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	69.51	15.26	5.04
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	54.56	11.22	4.84
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	80.10	14.67	5.45
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	143.80	15.65	7.97
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	172.60	21.11	9.38
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	7.62	1.43	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	82.45	15.66	5.63
Smooth Muscle Cells - Uterine, donor1	11258-116F7	190.24	28.94	13.92
Smooth Muscle Cells - Uterine, donor3	11466-119B8	85.73	11.12	5.27
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.09	16.33	3.69
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	60.82	9.78	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	119.39	9.67	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	96.30	21.92	5.39
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	53.09	16.47	3.12
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	92.56	9.85	3.15
Smooth muscle cells - airway, control, donor1	11966-126D4	83.04	10.92	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	69.48	11.98	2.80
Smooth muscle cells - airway, control, donor3	11968-126D6	49.74	13.38	4.60
Smooth muscle cells - airway, control, donor4	11969-126D7	68.30	11.00	2.75
Synoviocyte, donor1	11291-117A4	94.26	17.17	2.02
Synoviocyte, donor2	11368-117I9	130.58	31.18	6.37
Synoviocyte, donor3	11440-118H9	72.83	17.43	5.14
Trabecular Meshwork Cells, donor1	11532-120A2	72.90	17.15	3.57
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	3.96	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	31.72	6.02	4.17
Tracheal Epithelial Cells, donor1	11292-117A5	59.14	8.89	1.36
Tracheal Epithelial Cells, donor2	11369-118A1	35.18	13.14	4.25
Tracheal Epithelial Cells, donor3	11441-118I1	33.79	6.87	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	143.45	34.82	9.23
Urethra, donor2	10319-105A4	16.19	16.19	1.80
Urothelial Cells, donor1	11520-119H8	40.38	11.42	3.45
Urothelial Cells, donor2	11600-120H7	34.45	11.22	2.80
Urothelial Cells, donor3	11681-122H7	30.94	5.96	3.21
Urothelial cells, donor0	11216-116B1	100.75	13.82	5.57
Whole blood (ribopure), donor090309, donation1	12179-129A1	121.90	5.34	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	77.20	10.01	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.86	6.85	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	60.95	5.85	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	59.26	9.30	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	84.34	11.45	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	105.55	5.51	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	34.69	4.56	0.91
Wilms' tumor cell line:G-401	10809-111A8	79.20	27.14	8.27
Wilms' tumor cell line:HFWT	10597-108E3	74.80	56.32	13.20
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	106.98	24.30	8.94
achilles tendon, donor2	10292-104G4	64.06	2.07	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	127.48	10.71	5.35
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	107.96	26.70	6.50
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	124.88	12.94	4.63
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	193.47	18.78	9.25
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	111.87	17.71	3.65
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	166.65	41.87	10.57
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	130.39	12.79	4.90
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	229.13	50.67	8.81
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	168.65	20.42	4.49
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	95.13	20.97	5.44
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	109.66	18.95	4.42
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	159.92	35.10	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	131.30	23.24	5.58
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	103.04	22.01	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	113.98	20.75	4.09
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	107.36	18.13	3.72
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	137.77	20.97	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	54.02	39.90	13.81
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	202.26	38.40	11.95
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	192.89	36.40	12.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	193.53	32.25	7.94
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	108.92	20.49	2.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	57.70	7.34	3.34
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	22.30	13.01
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	159.70	15.82	5.65
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	71.96	17.45	7.41
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	91.85	39.36	18.74
adenocarcinoma cell line:IM95m	10796-110I4	104.80	38.86	9.42
adipose tissue, adult, pool1	10010-101C1	55.38	11.32	1.24
adipose, donor1	10184-103D4	112.00	19.35	14.66
adipose, donor2	10185-103D5	56.77	25.95	9.73
adipose, donor3	10186-103D6	94.21	19.88	5.72
adipose, donor4	10187-103D7	202.82	16.47	6.07
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	173.13	36.14	14.20
adrenal gland, adult, pool1	10081-102A9	87.30	21.83	14.55
adult T-cell leukemia cell line:ATN-1	10421-106C7	102.86	5.60	4.14
alveolar cell carcinoma cell line:SW 1573	10708-109H6	102.19	43.95	7.86
amniotic membrane cells, donor1	12235-129G3	90.42	40.57	14.84
amniotic membrane cells, donor2	12236-129G4	159.58	46.32	14.20
amniotic membrane cells, donor3	12237-129G5	63.04	25.04	11.19
amygdala - adult, donor10196	10167-103B5	26.09	11.86	3.56
amygdala, adult, donor10252	10151-102I7	34.06	16.83	3.85
amygdala, newborn, donor10223	10360-105E9	23.56	10.65	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	160.94	14.01	5.22
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	120.02	17.65	7.72
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	129.94	33.07	10.69
aorta, adult, pool1	10052-101G7	53.54	9.22	4.51
appendix, adult	10189-103D9	48.51	10.48	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	105.24	35.77	3.78
artery, adult	10190-103E1	19.02	10.87	4.08
astrocytoma cell line:TM-31	10425-106D2	85.04	16.51	3.33
b cell line:RPMI1788	10427-106D4	138.44	8.62	3.72
basal cell carcinoma cell line:TE 354.T	10702-109G9	169.52	31.07	6.38
bile duct carcinoma cell line:HuCCT1	10432-106D9	120.07	17.96	5.85
bile duct carcinoma cell line:TFK-1	10496-107C1	153.65	25.27	6.19
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	73.82	12.30	2.80
bladder, adult, pool1	10011-101C2	45.41	13.15	3.04
blood, adult, pool1	10053-101G8	59.79	6.64	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	55.66	23.98	8.56
bone marrow, adult	10192-103E3	87.73	20.24	0.67
brain, adult, donor1	10084-102B3	22.55	7.18	3.08
brain, adult, pool1	10012-101C3	30.96	10.36	1.89
brain, fetal, pool1	10085-102B4	45.41	24.04	2.67
breast carcinoma cell line:MCF7	10482-107A5	71.03	22.13	9.91
breast carcinoma cell line:MDA-MB-453	10419-106C5	189.48	41.57	9.61
breast, adult, donor1	10080-102A8	51.77	11.36	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	226.76	41.41	8.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	71.74	14.84	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	290.08	29.93	3.22
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	113.30	33.17	8.23
carcinoid cell line:NCI-H1770	10703-109H1	86.04	20.69	7.52
carcinoid cell line:NCI-H727	10735-110B6	153.02	22.75	7.88
carcinoid cell line:SK-PN-DW	10719-109I8	64.96	22.50	10.77
carcinosarcoma cell line:JHUCS-1	10642-109A3	114.46	28.48	5.06
caudate nucleus - adult, donor10196	10177-103C6	24.18	13.82	2.30
caudate nucleus, adult, donor10252	10164-103B2	33.30	12.21	3.18
caudate nucleus, adult, donor10258	10379-105H1	21.40	12.99	4.58
caudate nucleus, newborn, donor10223	10354-105E3	26.37	8.06	1.10
cerebellum - adult, donor10196	10173-103C2	58.27	26.22	0.00
cerebellum, adult, donor10252	10166-103B4	29.89	15.16	4.27
cerebellum, adult, pool1	10083-102B2	30.70	11.38	3.45
cerebellum, newborn, donor10223	10357-105E6	34.87	9.96	3.32
cerebral meninges, adult	10188-103D8	17.15	10.84	2.27
cerebrospinal fluid, donor2	10294-104G6	26.31	5.12	0.00
cervical cancer cell line:D98-AH2	10552-107I3	177.57	29.76	8.20
cervical cancer cell line:ME-180	10553-107I4	82.20	30.49	6.63
cervix, adult, pool1	10013-101C4	72.97	20.16	3.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	476.12	90.29	21.74
chondrosarcoma cell line:SW 1353	10700-109G7	48.33	15.68	5.23
choriocarcinoma cell line:BeWo	10423-106C9	240.23	31.57	10.56
choriocarcinoma cell line:SCH	10785-110H2	255.42	49.90	17.74
choriocarcinoma cell line:T3M-3	10618-108G6	95.11	26.80	11.62
chorionic membrane cells, donor1	12238-129G6	145.59	46.16	19.37
chorionic membrane cells, donor2	12239-129G7	160.08	31.62	14.12
chorionic membrane cells, donor3	12240-129G8	191.77	52.20	14.29
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	114.11	10.10	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	141.38	22.86	4.99
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	89.54	18.37	6.76
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	77.04	19.00	4.37
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	81.27	25.16	5.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	82.46	23.42	6.72
chronic myelogenous leukemia cell line:K562	10454-106G4	153.12	39.75	7.07
chronic myelogenous leukemia cell line:KU812	10409-106B4	135.00	21.11	4.69
clear cell carcinoma cell line:JHOC-5	10638-108I8	131.89	24.23	4.34
clear cell carcinoma cell line:TEN	10636-108I6	223.65	35.05	8.68
colon carcinoma cell line:CACO-2	10513-107D9	452.66	106.16	26.54
colon carcinoma cell line:COLO-320	10420-106C6	180.16	33.45	8.74
colon, adult, donor1	10082-102B1	82.11	24.99	4.76
colon, adult, pool1	10014-101C5	52.29	21.50	4.94
colon, fetal, donor1	10070-101I7	23.48	21.01	3.09
common myeloid progenitor CMP, donor1	12130-128D6	50.42	50.42	18.33
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	111.33	12.75	2.97
cord blood derived cell line:COBL-a 24h infection	10453-106G3	160.59	20.22	4.23
cord blood derived cell line:COBL-a untreated	10449-106F8	174.99	22.84	5.92
corpus callosum, adult, pool1	10042-101F6	65.90	12.71	3.87
cruciate ligament, donor2	10295-104G7	33.23	4.86	1.62
diaphragm, fetal, donor1	10069-101I6	35.31	14.45	7.22
diencephalon, adult	10193-103E4	22.56	9.84	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	58.09	5.97	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	153.09	44.62	3.85
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	85.22	15.41	8.91
ductus deferens, adult	10196-103E7	116.61	20.43	6.98
duodenum, fetal, donor1, tech_rep1	10071-101I8	96.50	18.72	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	89.01	30.16	2.94
dura mater, adult, donor1	10041-101F5	154.93	17.51	5.53
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	50.19	7.77	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	103.89	14.62	4.73
embryonic pancreas cell line:1B2C6	10604-108F1	48.71	33.91	4.32
embryonic pancreas cell line:1C3D3	10605-108F2	67.20	25.12	3.94
embryonic pancreas cell line:1C3IKEI	10606-108F3	67.62	38.90	7.41
embryonic pancreas cell line:2C6	10603-108E9	78.81	40.72	7.88
endometrial carcinoma cell line:OMC-2	10497-107C2	128.04	39.55	11.06
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	124.15	39.33	4.89
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	111.28	16.56	7.08
epidermoid carcinoma cell line:A431	10426-106D3	119.61	29.68	10.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	191.48	53.01	21.12
epididymis, adult	10197-103E8	89.59	21.35	4.19
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	131.28	52.69	8.87
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	64.88	29.49	3.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	170.89	36.82	19.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	167.81	38.48	19.88
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	177.01	37.31	24.87
esophagus, adult, pool1	10015-101C6	59.88	15.61	4.78
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	151.66	56.36	9.64
eye - muscle inferior rectus, donor1	10272-104E2	31.39	16.90	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	4.21	2.10
eye - muscle medial, donor2	10299-104H2	14.88	13.39	0.00
eye - muscle superior, donor2	10297-104G9	18.34	11.46	1.15
eye - vitreous humor, donor1	10268-104D7	36.43	10.20	0.00
eye, fetal, donor1	10054-101G9	58.73	23.64	6.10
fibrosarcoma cell line:HT-1080	10758-110E2	127.97	11.03	5.90
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	128.44	14.96	3.80
frontal lobe, adult, pool1	10040-101F4	39.97	13.04	1.60
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	130.61	36.63	8.41
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	231.33	40.96	7.13
gall bladder, adult	10198-103E9	66.39	18.35	3.86
gamma delta positive T cells, donor1	11937-126A2	122.94	10.20	3.76
gamma delta positive T cells, donor2	11938-126A3	114.66	10.08	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	115.11	23.66	8.66
gastric adenocarcinoma cell line:MKN45	10612-108F9	216.63	59.19	17.02
gastric cancer cell line:AZ521	10549-107H9	146.41	48.69	15.90
gastric cancer cell line:GSS	10560-108A2	161.99	29.29	8.24
gastrointestinal carcinoma cell line:ECC12	10615-108G3	82.70	9.82	3.66
giant cell carcinoma cell line:LU65	10487-107B1	61.39	12.28	1.61
giant cell carcinoma cell line:Lu99B	10433-106E1	91.25	12.60	5.18
glassy cell carcinoma cell line:HOKUG	10688-109F4	77.07	45.14	5.99
glioblastoma cell line:A172, tech_rep1	10444-106F3	69.66	22.48	5.17
glioblastoma cell line:A172, tech_rep2	10444-106F3	63.62	26.40	7.58
glioblastoma cell line:T98G	10485-107A8	193.59	34.88	7.84
glioma cell line:GI-1	10413-106B8	212.04	33.68	19.62
globus pallidus - adult, donor10196	10175-103C4	31.34	15.31	4.37
globus pallidus, adult, donor10252	10161-103A8	41.98	10.74	4.88
globus pallidus, adult, donor10258	10367-105F7	21.91	13.69	2.74
globus pallidus, newborn, donor10223	10364-105F4	29.84	11.72	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	83.20	17.13
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	162.02	26.13	0.00
granulosa cell tumor cell line:KGN	10624-108H3	60.48	24.64	2.88
hIPS +CCl2, biol_rep1	14383-156B9	131.77	23.87	9.64
hIPS +CCl2, biol_rep2	14384-156C1	118.89	22.41	10.06
hIPS +CCl2, biol_rep3	14385-156C2	126.24	21.90	10.31
hIPS, biol_rep1	14380-156B6	107.80	20.12	1.44
hIPS, biol_rep2	14381-156B7	119.34	17.15	6.17
hIPS, biol_rep3	14382-156B8	55.17	16.55	2.21
hairy cell leukemia cell line:Mo	10712-109I1	79.88	5.75	2.87
heart - mitral valve, adult	10205-103F7	41.86	14.35	2.99
heart - pulmonic valve, adult	10206-103F8	28.24	9.15	2.88
heart - tricuspid valve, adult	10207-103F9	55.79	23.31	3.33
heart, adult, diseased post-infarction, donor1	10050-101G5	114.68	34.69	10.00
heart, adult, diseased, donor1	10051-101G6	51.10	19.16	6.39
heart, adult, pool1	10016-101C7	26.68	27.60	7.13
heart, fetal, pool1	10046-101G1	64.89	18.59	6.37
hepatic mesenchymal tumor cell line:LI90	10778-110G4	201.77	33.94	17.28
hepatoblastoma cell line:HuH-6	10633-108I3	83.24	36.86	8.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	235.25	68.84	31.71
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	267.27	74.40	35.81
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	255.77	70.13	33.25
hepatoma cell line:Li-7	10484-107A7	188.40	25.25	7.34
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	101.91	12.06	8.64
hippocampus - adult, donor10196	10169-103B7	34.07	10.41	2.84
hippocampus, adult, donor10252	10153-102I9	33.06	16.12	3.88
hippocampus, adult, donor10258	10374-105G5	25.40	10.95	1.49
hippocampus, newborn, donor10223	10363-105F3	22.56	14.45	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	157.47	23.80	8.54
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	109.96	22.38	5.69
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	100.29	20.57	7.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	82.89	27.07	7.89
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	97.60	25.05	10.59
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	125.27	30.75	8.73
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	63.06	20.14	3.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	84.88	23.48	7.54
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	79.24	25.86	5.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	115.32	26.05	7.10
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	86.79	25.88	5.30
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	105.71	34.34	8.75
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	99.52	21.91	6.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	97.28	22.11	10.32
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	116.08	16.58	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	104.05	30.74	9.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	108.15	34.01	10.03
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	83.46	21.49	9.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	93.07	15.64	4.14
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	97.31	15.92	6.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	78.00	21.30	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	96.67	24.99	6.21
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	112.35	27.29	7.26
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	81.01	26.60	4.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	90.34	19.77	7.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	126.67	22.82	9.13
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	123.72	25.72	7.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	88.02	23.94	6.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	120.68	23.12	6.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	90.48	23.91	6.96
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	102.39	31.54	6.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	114.90	25.90	10.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	67.47	21.29	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	106.61	24.54	5.88
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	122.67	33.32	10.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	98.13	24.87	6.05
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	124.62	27.53	8.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	101.16	22.73	3.12
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	96.10	33.66	8.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	117.05	32.70	9.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	198.45	16.27	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	138.33	21.18	8.94
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	106.18	21.34	7.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	94.09	19.90	6.15
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	80.78	13.88	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	88.31	23.87	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	129.20	31.28	7.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	77.59	21.01	5.66
immature langerhans cells, donor1	11904-125F5	76.76	6.78	1.70
immature langerhans cells, donor2	11905-125F6	72.08	10.30	3.96
insula, adult, pool1	10039-101F3	42.11	14.95	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	77.71	34.47	8.78
kidney, adult, pool1	10017-101C8	111.14	23.63	3.50
kidney, fetal, pool1	10045-101F9	95.14	23.13	5.94
large cell lung carcinoma cell line:IA-LM	10509-107D5	148.27	33.80	5.11
large cell lung carcinoma cell line:NCI-H460	10839-111E2	137.55	30.00	12.99
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	57.99	18.53	5.32
left atrium, adult, donor1	10079-102A7	40.32	15.26	3.81
left ventricle, adult, donor1	10078-102A6	28.32	16.69	3.54
leiomyoblastoma cell line:G-402	10721-110A1	73.87	40.49	9.30
leiomyoma cell line:10964C	10569-108B2	108.49	27.66	9.34
leiomyoma cell line:15242A	10570-108B3	117.94	21.74	4.89
leiomyoma cell line:15425	10571-108B4	134.03	26.71	6.31
leiomyosarcoma cell line:Hs 5.T	10722-110A2	69.84	38.10	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	42.87	26.14	5.23
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	154.77	19.83	7.32
liposarcoma cell line:KMLS-1	10782-110G8	201.51	34.37	12.65
liposarcoma cell line:SW 872	10726-110A6	181.54	34.60	16.33
liver, adult, pool1	10018-101C9	161.74	35.33	13.61
liver, fetal, pool1	10086-102B5	75.26	34.81	12.23
locus coeruleus - adult, donor10196	10182-103D2	17.50	7.44	0.87
locus coeruleus, adult, donor10252	10165-103B3	34.70	9.41	2.40
locus coeruleus, adult, donor10258	10375-105G6	31.88	10.16	1.69
locus coeruleus, newborn, donor10223	10362-105F2	53.42	5.47	1.68
lung adenocarcinoma cell line:A549	10499-107C4	115.56	25.74	8.86
lung adenocarcinoma cell line:PC-14	10408-106B3	48.26	35.85	5.52
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	70.13	21.35	5.93
lung, adult, pool1	10019-101D1	78.08	14.06	4.25
lung, fetal, donor1	10068-101I5	93.04	17.12	3.71
lung, right lower lobe, adult, donor1	10075-102A3	80.65	15.58	3.21
lymph node, adult, donor1	10077-102A5	88.99	11.83	5.21
lymphangiectasia cell line:DS-1	10727-110A7	507.18	33.10	19.95
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	87.99	7.40	3.32
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	60.31	14.44	3.40
mature adipocyte, donor1	12231-129F8	29.30	16.87	5.33
mature adipocyte, donor2	12232-129F9	41.09	12.66	3.53
mature adipocyte, donor3	12233-129G1	46.23	15.65	4.74
mature adipocyte, donor4	12234-129G2	35.53	10.53	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	257.08	58.85	13.58
medial frontal gyrus - adult, donor10196	10170-103B8	21.43	11.28	3.38
medial frontal gyrus, adult, donor10252	10150-102I6	26.85	8.46	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	23.19	9.21	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	25.59	5.97	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	21.94	9.45	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	27.38	11.67	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	30.82	3.85	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	22.25	8.97	1.44
medulla oblongata - adult, donor10196	10174-103C3	57.11	12.33	5.19
medulla oblongata, adult, donor10252	10155-103A2	38.86	11.30	4.18
medulla oblongata, adult, pool1	10038-101F2	48.57	9.71	2.20
medulla oblongata, newborn, donor10223	10361-105F1	30.20	7.29	1.74
medulloblastoma cell line:D283 Med	10838-111E1	111.59	19.04	4.65
medulloblastoma cell line:ONS-76	10759-110E3	152.35	28.37	12.84
melanoma cell line:COLO 679	10514-107E1	171.63	28.17	8.19
melanoma cell line:G-361	10465-106H6	139.26	21.45	5.70
meningioma cell line:HKBMM	10691-109F7	106.19	11.58	2.89
merkel cell carcinoma cell line:MKL-1	10843-111E6	69.61	20.27	8.81
merkel cell carcinoma cell line:MS-1	10844-111E7	114.32	28.77	5.96
mesenchymal precursor cell - adipose, donor1	11747-123G1	164.63	21.63	12.12
mesenchymal precursor cell - adipose, donor2	11748-123G2	121.79	14.18	5.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	118.85	19.88	3.73
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	105.92	16.15	4.64
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	148.86	21.38	9.05
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	165.19	36.09	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	233.08	22.83	12.19
mesenchymal precursor cell - cardiac, donor2	11753-123G7	116.86	16.10	6.44
mesenchymal precursor cell - cardiac, donor3	11754-123G8	145.37	16.98	7.83
mesenchymal precursor cell - cardiac, donor4	11755-123G9	171.91	20.53	7.16
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	138.42	19.49	7.40
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	164.02	16.47	4.94
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	120.94	17.85	8.03
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	132.65	24.78	4.54
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	152.72	24.30	9.19
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	111.43	17.61	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	175.55	24.10	9.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	108.07	17.10	5.47
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	139.71	18.88	4.62
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	134.20	17.04	6.87
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	148.10	22.06	7.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	138.06	22.09	3.31
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	111.60	19.17	3.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	102.73	18.95	4.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	103.21	21.46	4.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	86.71	16.88	4.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	109.15	18.85	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	87.19	19.41	3.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	89.20	17.89	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	98.15	19.97	2.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	92.74	18.47	3.14
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	90.36	16.68	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	111.91	20.77	4.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	99.73	22.76	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	102.87	18.75	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	83.60	25.67	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	93.65	20.14	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	88.84	18.42	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	100.09	15.89	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	84.77	19.14	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	82.64	20.66	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	87.37	18.19	5.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	101.85	14.55	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	110.35	23.46	4.26
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	85.05	22.08	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	87.46	17.10	2.72
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	73.46	18.89	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	90.41	11.92	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	19.07	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	87.76	18.97	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	106.01	21.93	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	114.01	25.34	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	97.26	21.38	3.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	83.82	23.64	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	87.82	11.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	106.76	13.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	102.68	19.15	3.26
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	112.81	19.07	7.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	76.05	11.79	6.48
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	80.11	19.01	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	69.51	17.38	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	61.50	11.83	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	43.66	23.11	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	62.64	17.90	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	89.07	16.33	11.88
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	77.38	21.31	6.73
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	90.32	22.90	5.09
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	76.57	22.16	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	78.50	13.08	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	68.42	26.61	10.14
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	80.11	23.67	10.32
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	36.15	18.08
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	67.54	29.65	10.71
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	76.99	20.24	2.58
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	66.52	15.90	3.24
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	68.25	11.20	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	16.25	21.66	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	127.10	44.41	14.65
mesothelioma cell line:ACC-MESO-4	10494-107B8	164.02	35.91	10.43
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	17.09	8.55
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.14	10.89	3.70
mesothelioma cell line:Mero-25	10850-111F4	157.05	13.84	5.22
mesothelioma cell line:Mero-41	10851-111F5	131.77	20.05	2.20
mesothelioma cell line:Mero-48a	10852-111F6	147.92	24.36	7.09
mesothelioma cell line:Mero-82	10853-111F7	102.49	14.45	4.73
mesothelioma cell line:Mero-83	10854-111F8	92.26	16.85	7.66
mesothelioma cell line:Mero-84	10855-111F9	104.65	20.22	4.30
mesothelioma cell line:Mero-95	10856-111G1	136.03	20.08	6.00
mesothelioma cell line:NCI-H2052	10847-111F1	143.12	15.57	4.31
mesothelioma cell line:NCI-H226	10846-111E9	87.96	16.11	4.71
mesothelioma cell line:NCI-H2452	10848-111F2	142.47	23.92	7.86
mesothelioma cell line:NCI-H28	10845-111E8	54.96	30.03	4.83
mesothelioma cell line:No36	10857-111G2	88.73	28.71	9.13
mesothelioma cell line:ONE58	10858-111G3	87.25	17.34	1.63
migratory langerhans cells, donor1	11901-125F2	75.04	2.49	0.77
migratory langerhans cells, donor2	11902-125F3	54.34	2.93	0.49
migratory langerhans cells, donor3	11903-125F4	75.92	1.97	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	231.15	32.65	6.53
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	162.34	27.34	17.17
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	76.25	15.66	2.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	59.37	8.37	5.71
myelodysplastic syndrome cell line:SKM-1	10772-110F7	229.14	42.87	11.46
myeloma cell line:PCM6	10474-106I6	242.74	16.80	6.33
myxofibrosarcoma cell line:MFH-ino	10600-108E6	32.97	16.23	10.15
myxofibrosarcoma cell line:NMFH-1	10684-109E9	173.19	26.48	5.88
nasal epithelial cells, donor1, tech_rep1	12226-129F3	98.50	12.26	4.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	98.25	9.12	2.13
nasal epithelial cells, donor2	12227-129F4	172.77	15.46	7.18
neuroblastoma cell line:CHP-134	10508-107D4	171.40	52.22	10.81
neuroblastoma cell line:NB-1	10539-107G8	130.77	55.75	12.16
neuroblastoma cell line:NBsusSR	10607-108F4	286.18	32.06	13.50
neuroblastoma cell line:NH-12	10555-107I6	106.03	18.82	5.96
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	39.38	11.39	4.74
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	106.43	24.23	7.92
neuroectodermal tumor cell line:TASK1	10774-110F9	125.38	18.31	7.85
neuroepithelioma cell line:SK-N-MC	10728-110A8	48.95	34.97	13.35
neurofibroma cell line:Hs 53.T	10729-110A9	99.81	19.70	8.78
neutrophil PMN, donor1	12133-128D9	29.75	14.87	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	13.28
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	182.65	21.82	9.13
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	131.28	30.42	11.21
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	172.17	30.46	8.66
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	125.34	29.69	4.73
nucleus accumbens, adult, pool1	10037-101F1	44.53	14.15	3.09
occipital cortex - adult, donor10196	10172-103C1	30.91	10.30	2.06
occipital cortex, adult, donor10252	10163-103B1	28.71	12.34	3.76
occipital cortex, newborn, donor10223	10355-105E4	21.84	9.46	0.73
occipital lobe, adult, donor1	10076-102A4	27.29	12.60	2.10
occipital lobe, fetal, donor1	10073-102A1	64.79	30.47	2.57
occipital pole, adult, pool1	10036-101E9	36.11	11.27	2.21
olfactory region, adult	10195-103E6	26.37	8.41	3.06
optic nerve, donor1	10277-104E7	30.02	8.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	279.76	40.32	9.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	119.53	37.09	4.95
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	65.87	18.96	2.54
oral squamous cell carcinoma cell line:SAS	10544-107H4	113.43	28.76	4.16
osteoclastoma cell line:Hs 706.T	10704-109H2	94.36	22.64	4.70
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	69.14	27.10	7.47
osteosarcoma cell line:HS-Os-1	10558-107I9	224.99	33.51	16.75
ovary, adult, pool1	10020-101D2	64.90	12.93	3.93
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	170.30	28.41	14.85
pancreas, adult, donor1	10049-101G4	118.52	35.74	14.11
pancreatic carcinoma cell line:NOR-P1	10698-109G5	122.44	43.33	13.14
papillary adenocarcinoma cell line:8505C	10437-106E5	178.70	35.09	4.43
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	79.48	18.21	4.31
paracentral gyrus, adult, pool1	10035-101E8	34.96	8.51	1.28
parietal cortex, adult, donor10258	10373-105G4	82.94	6.61	1.47
parietal lobe - adult, donor10196	10171-103B9	22.57	12.23	1.88
parietal lobe, adult, donor10252	10157-103A4	21.38	10.26	2.28
parietal lobe, adult, pool1	10034-101E7	34.37	12.87	2.73
parietal lobe, fetal, donor1	10072-101I9	44.61	37.82	2.91
parietal lobe, newborn, donor10223	10356-105E5	22.43	9.72	0.00
parotid gland, adult	10199-103F1	102.98	19.73	11.72
penis, adult	10200-103F2	44.58	12.35	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.68	7.25	2.23
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	209.36	41.38	16.32
pineal gland - adult, donor10196	10179-103C8	81.92	30.96	5.81
pineal gland, adult, donor10252	10160-103A7	103.04	25.47	3.55
pineal gland, adult, donor10258	10377-105G8	59.57	13.80	0.00
pituitary gland - adult, donor10196	10180-103C9	67.79	25.30	5.06
pituitary gland, adult, donor10252	10162-103A9	109.97	30.75	6.25
pituitary gland, adult, donor10258	10378-105G9	74.91	12.77	3.40
placenta, adult, pool1	10021-101D3	185.33	67.08	10.11
plasma cell leukemia cell line:ARH-77	10840-111E3	92.70	9.01	2.65
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	125.76	26.61	11.52
pons, adult, pool1	10033-101E6	32.36	9.55	1.64
postcentral gyrus, adult, pool1	10032-101E5	36.61	9.68	2.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	18.82	62.74	27.19
promyelocytes/myelocytes PMC, donor2	12136-128E3	209.31	16.52	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	23.47	11.74
prostate cancer cell line:DU145	10490-107B4	176.54	43.41	9.47
prostate cancer cell line:PC-3	10439-106E7	213.99	42.11	16.34
prostate, adult, pool1	10022-101D4	64.21	17.68	4.53
putamen, adult, donor10196	10176-103C5	27.86	12.75	3.30
putamen, adult, donor10252	10152-102I8	33.33	9.80	9.80
putamen, adult, donor10258, tech_rep1	10372-105G3	50.27	10.93	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	23.44	10.15	1.21
putamen, newborn, donor10223	10365-105F5	50.23	3.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	104.45	34.62	17.75
rectum, fetal, donor1	10067-101I4	58.42	22.26	6.95
renal cell carcinoma cell line:OS-RC-2	10411-106B6	401.95	39.64	5.72
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	74.97	24.02	7.04
retina, adult, pool1	10030-101E3	116.99	18.49	4.97
retinoblastoma cell line:Y79	10475-106I7	101.32	34.03	6.24
rhabdomyosarcoma cell line:KYM-1	10787-110H4	73.77	19.92	7.75
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	90.27	27.84	4.22
sacrococcigeal teratoma cell line:HTST	10695-109G2	45.47	16.67	3.03
salivary acinar cells, donor1	11771-123I7	46.29	12.46	2.43
salivary acinar cells, donor2	11772-123I8	44.34	9.23	1.79
salivary acinar cells, donor3	11773-123I9	16.55	13.24	4.63
salivary gland, adult, pool1	10093-102C3	174.45	26.31	8.58
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	52.86	10.20	1.18
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	53.84	7.99	1.65
seminal vesicle, adult	10201-103F3	106.34	25.40	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	50.53	25.51	4.37
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	71.46	11.07	3.02
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	105.37	17.06	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	180.39	47.28	12.76
signet ring carcinoma cell line:Kato III	10436-106E4	191.10	39.13	5.53
signet ring carcinoma cell line:NUGC-4	10483-107A6	85.29	38.32	6.19
skeletal muscle - soleus muscle, donor1	10282-104F3	21.28	12.77	4.26
skeletal muscle, adult, pool1	10023-101D5	44.74	13.31	5.64
skeletal muscle, fetal, donor1	10066-101I3	40.20	14.07	1.01
skin, adult, donor1	10074-102A2	54.28	6.79	0.00
skin, fetal, donor1	10065-101I2	80.80	29.04	7.57
small cell cervical cancer cell line:HCSC-1	10800-110I8	188.44	45.69	15.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	69.98	20.17	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	88.86	26.02	7.90
small cell lung carcinoma cell line:LK-2	10541-107H1	128.89	32.47	4.78
small cell lung carcinoma cell line:NCI-H82	10842-111E5	104.71	17.53	5.15
small cell lung carcinoma cell line:WA-hT	10562-108A4	141.65	25.71	11.99
small intestine, adult, pool1	10024-101D6	93.28	35.59	9.08
small intestine, fetal, donor1	10064-101I1	64.37	22.85	4.67
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	210.29	42.57	5.64
smooth muscle, adult, pool1	10048-101G3	41.87	12.92	4.14
somatostatinoma cell line:QGP-1	10781-110G7	100.24	26.80	6.97
spinal cord - adult, donor10196	10181-103D1	33.03	11.47	0.69
spinal cord, adult, donor10252	10159-103A6	40.61	9.07	5.52
spinal cord, adult, donor10258	10369-105F9	61.57	2.77	0.69
spinal cord, fetal, donor1	10056-101H2	55.50	25.00	6.10
spinal cord, newborn, donor10223	10359-105E8	52.35	5.51	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	106.94	21.96	8.36
spleen, adult, pool1	10025-101D7	97.91	15.20	3.41
spleen, fetal, pool1	10044-101F8	88.75	13.51	3.89
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	148.02	9.94	3.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	48.23	16.90	2.09
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	190.80	60.11	8.74
squamous cell carcinoma cell line:T3M-5	10616-108G4	114.15	20.72	5.47
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	159.38	29.38	4.61
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	122.42	38.12	6.35
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	40.61	17.35	8.46
stomach, fetal, donor1	10062-101H8	68.35	44.85	7.48
submaxillary gland, adult	10202-103F4	100.83	21.08	5.70
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	44.03	12.46	3.74
substantia nigra, adult, donor10258	10371-105G2	34.66	8.79	0.52
substantia nigra, newborn, donor10223	10358-105E7	29.68	13.42	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	126.33	38.29	13.53
temporal lobe, adult, pool1	10031-101E4	34.76	14.67	2.29
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.16	39.89	7.12
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	39.12	18.46	0.88
tenocyte, donor1	11763-123H8	175.60	30.72	10.47
tenocyte, donor2	11765-123I1	99.19	25.94	2.67
tenocyte, donor3	11768-123I4	106.38	25.95	4.45
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	111.83	28.21	7.82
teratocarcinoma cell line:NCR-G1	10798-110I6	159.24	16.80	14.03
teratocarcinoma cell line:PA-1	10807-111A6	143.20	25.11	11.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	147.01	48.75	23.74
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	160.72	32.52	3.40
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	118.77	25.19	17.01
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	89.57	34.20	2.61
testis, adult, pool1	10026-101D8	112.74	29.53	6.66
testis, adult, pool2	10096-102C6	145.70	31.58	4.96
thalamus - adult, donor10196	10168-103B6	22.08	11.04	2.21
thalamus, adult, donor10252	10154-103A1	33.76	10.31	4.06
thalamus, adult, donor10258, tech_rep1	10370-105G1	7.70	4.62	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	21.57	6.59	1.48
thalamus, newborn, donor10223	10366-105F6	21.86	8.63	0.58
throat, adult	10209-103G2	39.45	11.73	3.25
throat, fetal, donor1	10061-101H7	69.47	23.46	8.53
thymic carcinoma cell line:Ty-82	10803-111A2	99.37	22.85	3.97
thymus, adult, pool1	10027-101D9	63.72	8.45	3.78
thymus, fetal, pool1	10043-101F7	74.50	10.08	4.26
thyroid carcinoma cell line:KHM-5M	10776-110G2	178.83	27.66	7.18
thyroid carcinoma cell line:TCO-1	10783-110G9	116.08	14.81	6.15
thyroid, adult, pool1	10028-101E1	126.91	28.46	9.70
thyroid, fetal, donor1	10060-101H6	98.35	30.85	4.75
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	9.24	0.00
tongue, adult	10203-103F5	43.03	14.19	1.63
tongue, fetal, donor1	10059-101H5	61.08	16.95	5.12
tonsil, adult, pool1	10047-101G2	108.59	18.53	4.71
trachea, adult, pool1	10029-101E2	110.76	20.86	5.48
trachea, fetal, donor1	10058-101H4	88.48	22.31	7.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	106.28	20.55	11.34
transitional-cell carcinoma cell line:5637	10418-106C4	203.95	27.15	8.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	140.55	27.11	2.51
tridermal teratoma cell line:HGRT	10694-109G1	53.27	19.03	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	140.18	33.10	8.89
umbilical cord, fetal, donor1	10057-101H3	54.25	16.69	4.17
uterus, adult, pool1	10100-102D1	98.79	20.48	5.80
uterus, fetal, donor1	10055-101H1	74.23	29.18	9.73
vagina, adult	10204-103F6	38.13	9.69	5.82
vein, adult	10191-103E2	39.67	7.45	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	60.88	5.61	2.94